FDA's Internet Promotion Policy: Christmas Cards In Lieu Of Guidance?
Industry will ring in the New Year with no more guidance from FDA on Internet and social media promotion than the warning and untitled letters that FDA has issued during the past several years.
You may also be interested in...
In the absence of clear policy from the agency, GSK keeps careful eyes on Facebook, but experts disagree on the extent to which drug companies are required to actively monitor social media sites.
Certain drug classes will be required to submit certain types of ads, according to Tom Abrams, director of CDER’s recently elevated Office of Prescription Drug Promotion, but specifics will await the guidance itself.
Reintegrating the principles in its seminal citations of search engine ads, DDMAC tells Pfizer to stop including "riskless" links for named drugs as part of its Lipitor website.